Diclofenac associated with cardiovascular health risk

0
A 20-year population-based study has found the use of diclofenac for pain relief is linked to an increased risk of major adverse cardiovascular events...

Systemic corticosteroids for dyspnoea

0
The effectiveness of systemic corticosteroids for the management of dyspnoea in adults with advanced cancer. Dyspnoea affects almost 70% of advanced cancer patients at the...

PSA National President opening address at PSA24

0
Read the transcript of the speech delivered by PSA National President Associate Professor Fei Sim FPS at PSA24 today (2 August).

Ethical lessons for Australian pharmacists from overseas

0
What ethical lessons do Australian pharmacists need to heed from other countries? A panel of experts at the FIP Congress filled in the blanks.

Pharmacist on the rise

0
Ayomide Ogundipe’s initiative, commitment to patient-centred care, and leadership while interning at Pharmacy777 in Perth has earned her PSA’s Intern of the Year award. Ms...

Cost of asthma treatment – a deterrent to use

0
Cost is a major factor associated with non-adherence to asthma treatment in Australia, recent research revealed. Healthcare providers can assist patients with adherence by...